Am J Transplant, Volume 19, Suppl 3 Archives - Page 200 of 214 - ATC Abstracts

2019 American Transplant Congress
The Impact of Removing DSA as a First Unit of Lung Allocation: Preliminary Results
R. R. Lehman¹, K. Uccellini², M. Skeans³, M. Valapour³, E. D. Lease⁴, R. Daly⁵, K. M. Chan⁶
¹Research, United Network for Organ Sharing, Richmond, VA, ²Policy, United Network for Organ Sharing, Richmond, VA, ³SRTR, Minneapolis, MN, ⁴Univ of Washington, Seattle, WA, ⁵Mayo Clinic, Rochester, MN, ⁶Univ of Michigan, Ann Arbor, MI
*Purpose: In an emergency action on November 24, 2017 the Organ Procurement and Transplantation Network (OPTN) altered US lung allocation policy by replacing the donor…
2019 American Transplant Congress
Circulating Mirnas Regulate Gene Expression In Kidney Tissue During Transplant Glomerulopathy
C. Kuscu¹, V. Sai Bontha¹, C. Kuscu¹, D. Maluf¹, A. Bajwa¹, J. Eason¹, V. Mas¹, E. Akalin²
¹UTHSC, Memphis, TN, ²Albert Einstein College of Medicine, NYC, NY
*Purpose: Post-transplant glomerular disease includes membranous glomerulopathy (MG), secondary or primary focal segmental glomerulosclerosis (FSGS). Furthermore, at post transplant, TG is an important cause of…
2019 American Transplant Congress
Predictors and Outcomes of Acute Graft-versus-Host Disease after Liver Transplant
A. Caines¹, S. Nagai², R. Salgia¹
¹Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI, ²Transplant Surgery, Henry Ford Health System, Detroit, MI
*Purpose: Graft-versus-Host Disease (GVHD) is a rare complication of liver transplant (LT) that has an estimated incidence of 0.1%-2% per year and is associated with…
2019 American Transplant Congress
Evaluation of Medication Burden in Kidney Transplant Recipients at Time of Index Hospitalization
J. Hardcopf¹, H. Meadows¹, T. Harrison¹, H. Corbo¹, B. O'brien¹, J. N. Fleming¹, C. Perez¹, N. Patel¹, N. Pilch¹, P. K. Baliga², D. DuBay², D. Taber¹
¹Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC, ²Division of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: This study will assess whether a higher number of medication changes from pre- to post-transplant lead to worse clinical outcomes and higher healthcare utilization…
2019 American Transplant Congress
Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients
M. van der Zwan, D. A. Hesselink, M. C. Clahsen-van Groningen, C. C. Baan
Erasmus MC, Rotterdam, Netherlands
*Purpose: There is an unmet need for reliable minimally-invasive diagnostic biomarkers for immunological allograft monitoring and detection of acute kidney transplant rejection. Here, targeted proteomic…
2019 American Transplant Congress
Utilizing Ides To Eliminate Residual Antibodies Targeting Xenografts
C. Rickert, K. Lee, N. Tanimine, J. Lei, A. Cuenca, N. Feeney, K. Deng, H. Yeh, J. F. Markmann
Massachusetts General Hospital, Boston, MA
*Purpose: A significant hinderance to the successful use of xenotransplantation has been the presence of preformed antibodies against the donor antigens, known as xenoantigens. Using…
2019 American Transplant Congress
Comparison of Minimal Incision Kidney Transplantation with Conventional Incision Kidney Transplantation: Interim Report of a Randomized Controlled Trial
T. Lin, T. Song, Y. Jiang, Y. Fan, X. Wang, Z. Huang, J. Liu, Z. Wang
Organ Transplantation Center, Urology Department, Urology Research Institute, WestChina Hospital, Sichuan University, Chengdu, China
*Purpose: Minimally invasive surgery is rarely applied in kidney transplantation. Few studies have mentioned small incision kidney transplantation, while the incision length is still about…
2019 American Transplant Congress
Expansion of Regulatory T and B Cells in Swine Rendered Tolerant of Allogeneic Vascularized Composite Allografts via Mixed Chimerism
G. Saviane¹, A. Lellouch¹, A. Andrews¹, L. Lantieri², M. Randolph¹, G. Benichou¹, C. Cetrulo Jr¹
¹Center for Transplantation Sciences, Division of Plastic Surgery, Boston, MA, USA, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA, ²European Georges Pompidou Hospital, University of Paris, Department of Plastic Surgery, Paris, France
*Purpose: Prevention of acute rejection of vascularized composite allografts (VCAs) requires ongoing systemic immunosuppression, which subject patients to infectious, metabolic, reno-vascular and neoplastic complications. It…
2019 American Transplant Congress
The More You Wait, the More You Lose: Prostatectomy and Kidney Transplant Waiting Time in End Stage Renal Disease
N. Sarabu¹, N. Schiltz², K. D. Chavin¹, D. E. Hricik¹
¹University Hospitals of Cleveland, Cleveland, OH, ²Case Western Researve University, Cleveland, OH
*Purpose: Optimal treatment and waiting time for patients with prostate cancer awaiting kidney transplant is unclear.*Methods: We studied male patients, 40 years or older, with…
2019 American Transplant Congress
A Comparison of the BAR, DRM, DRI, sRRI, ET-DRI, D-MELD and SOFT Score to Predict Outcome after Liver Transplantation in the SRTR Database
J. D. de Boer¹, H. Putter², J. J. Blok¹, I. P. Alwayn¹, B. Van Hoek³, A. E. Braat¹
¹Transplant Center, Leiden University Medical Center, Leiden, Netherlands, ²Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands, ³Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
*Purpose: Several risk models have been developed to predict outcome after liver transplantation (LT) in the last decade. This study analyzes the ability of these…